论文部分内容阅读
充血性心力衰竭的传统疗法着重于应用正性收缩能药物和利尿剂,以增加心室搏出量和心输出量。近年来,血管扩张剂在心力衰竭治疗中的作用已引起广泛重视,如适应症和治疗方法选择得当,往往可收到传统疗法不能达到的疗效。血管扩张剂对心肌并无直接的正性收缩能作用,而主要作用于周围动静脉血管系统,以减轻心脏的后及前负荷,增加心输出量和节省耗氧量,从而有利于氧的供耗平衡,使心功能得到改善。我们自1978年1月至1979年6月曾应用血管扩张剂治疗急慢性心力衰竭40例,现报告如下。
Traditional therapies for congestive heart failure focus on the use of positive systolic and diuretics to increase ventricular stroke and cardiac output. In recent years, the role of vasodilators in the treatment of heart failure has attracted widespread attention, such as indications and treatment options properly, often can receive traditional therapies can not be achieved. Vasodilators do not have direct positive systolic effects on the myocardium but act primarily on the peripheral arteriovenous system to reduce post-cardiac and anterior cardiac load, increase cardiac output, and save oxygen, thus contributing to oxygen supply Consumption balance improves heart function. We have from January 1978 to June 1979 had vasodilators in the treatment of 40 cases of acute and chronic heart failure, are as follows.